Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 106 AL 120

Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology

Hajipour MJ, Santoso MR, Rezaee F, Aghaverdi H, Mahmoudi M, Perry G.

Trends Biotechnol. 2017 Oct;35(10):937-953. doi: 10.1016/j.tibtech.2017.06.002. Epub 2017 Jun 27.

Cholinergic symptoms and QTc prolongation following donepezil overdose

Pourmand A, Shay C, Redha W, Aalam A, Mazer-Amirshahi M.

Am J Emerg Med. 2017 Sep;35(9):1386.e1-1386.e3. doi: 10.1016/j.ajem.2017.06.044. Epub 2017 Jun 22.

Winning the Fight to End Alzheimer Disease

Dawson W.

JAMA Neurol. 2017 Aug 1;74(8):896-897. doi: 10.1001/jamaneurol.2017.1279.

Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease

Chiesa PA, Cavedo E, Lista S, Thompson PM, Hampel H; Alzheimer Precision Medicine Initiative (APMI).

Trends Neurosci. 2017 Aug;40(8):469-480. doi: 10.1016/j.tins.2017.06.002. Epub 2017 Jul 3.

A clinicopathological approach to the diagnosis of dementia

Elahi FM, Miller BL.

Nat Rev Neurol. 2017 Aug;13(8):457-476. doi: 10.1038/nrneurol.2017.96. Epub 2017 Jul 14.

Alzheimer's Disease: Dawn of a New Era?

Amirrad F, Bousoik E, Shamloo K, Al-Shiyab H, Nguyen VV, Montazeri Aliabadi H.

J Pharm Pharm Sci. 2017;20(0):184-225. doi: 10.18433/J3VS8P.

I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease Therapies

Messmer MF, Wilhelm EE, Shoulson I.

JAMA Neurol. 2017 Sep 1;74(9):1027-1028. doi: 10.1001/jamaneurol.2017.1528.

Cognitive behavioral therapy (CBT) for preventing Alzheimer's disease

Reid LD, Avens FE, Walf AA.

Behav Brain Res. 2017 Sep 15;334:163-177. doi: 10.1016/j.bbr.2017.07.024. Epub 2017 Jul 23.

The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial

Rijpma A, van der Graaf M, Lansbergen MM, Meulenbroek O, Cetinyurek-Yavuz A, Sijben JW, Heerschap A, Olde Rikkert MGM.

Alzheimers Res Ther. 2017 Jul 26;9(1):51. doi: 10.1186/s13195-017-0286-2.

A case of early-onset familial Alzheimer's disease with both APP and novel PSEN2 mutations presenting with non-amnestic features

Chee KY, Yee OK, Gaillard F, Velakoulis D, Mohd Zain NR, Yogendren L, Khim CL, Ariffin R.

Aust N Z J Psychiatry. 2017 Dec;51(12):1252-1253. doi: 10.1177/0004867417722642. Epub 2017 Aug 1.

Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial

Sindi S, Ngandu T, Hovatta I, Kåreholt I, Antikainen R, Hänninen T, Levälahti E, Laatikainen T, Lindström J, Paajanen T, Peltonen M, Khalsa DS, Wolozin B, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M, Solomon A; FINGER study group.

J Alzheimers Dis. 2017;59(4):1459-1470. doi: 10.3233/JAD-170123.

Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial

Park KW, Kim EJ, Han HJ, Shim YS, Kwon JC, Ku BD, Park KH, Yi HA, Kim KK, Yang DW, Lee HW, Kang H, Kwon OD, Kim S, Lee JH, Chung EJ, Park SW, Park MY, Yoon B, Kim BC, Seo SW, Choi SH.

PLoS One. 2017 Aug 7;12(8):e0182123. doi: 10.1371/journal.pone.0182123. eCollection 2017.

[Current and future prospects of nuclear medicine in dementia]

Ito K, Inui Y, Kizawa T, Kimura Y, Kato T.

Rinsho Shinkeigaku. 2017 Sep 30;57(9):479-484. doi: 10.5692/clinicalneurol.cn-001016. Epub 2017 Aug 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias